Epigenetic regulation of proinflammatory responses in the skin

皮肤促炎症反应的表观遗传调控

基本信息

  • 批准号:
    9313788
  • 负责人:
  • 金额:
    $ 36.29万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-11 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT We have shown that loss of the chromatin remodeler Mi-2β in the basal epidermis causes rapid up-regulation of pro-inflammatory and stress response genes in the absence of any overt environmental signals or a skin barrier defect. These data support the hypothesis that immune cell regulatory genes, normally induced in the epidermis by environmental insults, are directly and actively repressed by chromatin regulators, under conditions of epidermal homeostasis. We now propose to study the chromatin-based mechanisms by which immune-regulatory genes are kept poised for expression in keratinocytes and to determine how activation of signaling pathways by mechanical or environmental insult reverses these mechanisms. In the first aim, we will establish the “anti-inflammatory” chromatin landscape and transcription factor network that control keratinocyte homeostasis. Genome-wide approaches will be used in keratinocytes to establish the gene networks that are directly and functionally controlled by Mi-2β. The types of regulatory elements that Mi-2β associates with, and the chromatin configuration that they are in will be established. The sequence- specific DNA binding factors that functionally interact in a synergistic or antagonistic fashion with Mi-2β will be identified. Finally, the repertoire of chromatin regulators and transcription factors involved in pro-inflammatory gene regulation in a Mi-2β−independent fashion will be also established. In the second aim, we will determine how environmental signals induce pro- inflammatory gene expression in keratinocytes. The effect of environmental signals on altering the activity of both chromatin regulators and transcription factors will be studied. We will first examine the cause-effect relationship between Mi-2β and the epigenetic and transcription factor makeup at the regulatory domains of its target genes. We will then test how environmental signals induce pro-inflammatory genes by altering the activities of Mi- 2β and associated chromatin regulators and transcription factors. The role of key regulatory candidates in this molecular process will be further evaluated by genetic interference studies in mouse and human keratinocytes. The outcome of these studies will allow us to probe into conserved mechanisms that contribute to human skin disease with a pro-inflammatory basis and provide new avenues for therapeutic intervention.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KATIA GEORGOPOULOS其他文献

KATIA GEORGOPOULOS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KATIA GEORGOPOULOS', 18)}}的其他基金

Epigenetic regulation of epidermal proinflammatory responses
表皮促炎症反应的表观遗传调控
  • 批准号:
    10931159
  • 财政年份:
    2023
  • 资助金额:
    $ 36.29万
  • 项目类别:
Mechanisms of human pre-B cell differentiation
人类前B细胞分化的机制
  • 批准号:
    9102627
  • 财政年份:
    2016
  • 资助金额:
    $ 36.29万
  • 项目类别:
Mechanisms of human pre-B cell differentiation
人类前B细胞分化的机制
  • 批准号:
    9243971
  • 财政年份:
    2016
  • 资助金额:
    $ 36.29万
  • 项目类别:
Epigenetic regulation of proinflammatory responses in the skin
皮肤促炎症反应的表观遗传调控
  • 批准号:
    9177449
  • 财政年份:
    2016
  • 资助金额:
    $ 36.29万
  • 项目类别:
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
IKAROS 在高危前体 B 细胞白血病的生物学和治疗中的作用
  • 批准号:
    8974821
  • 财政年份:
    2014
  • 资助金额:
    $ 36.29万
  • 项目类别:
Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia
IKAROS 在高危前体 B 细胞白血病的生物学和治疗中的作用
  • 批准号:
    8802836
  • 财政年份:
    2014
  • 资助金额:
    $ 36.29万
  • 项目类别:
Epigenetic regulation of epidermal homeostasis
表皮稳态的表观遗传调控
  • 批准号:
    8584899
  • 财政年份:
    2013
  • 资助金额:
    $ 36.29万
  • 项目类别:
Ikaros regulation: study on hemo-lymphopoiesis
Ikaros 调节:造血淋巴细胞的研究
  • 批准号:
    8882314
  • 财政年份:
    2011
  • 资助金额:
    $ 36.29万
  • 项目类别:
Ikaros regulation: Study on hemolymphopoiesis
Ikaros 调节:血淋巴细胞生成的研究
  • 批准号:
    10437875
  • 财政年份:
    2011
  • 资助金额:
    $ 36.29万
  • 项目类别:
Ikaros regulation: study on hemo-lymphopoiesis
Ikaros 调节:造血淋巴细胞的研究
  • 批准号:
    8188058
  • 财政年份:
    2011
  • 资助金额:
    $ 36.29万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 36.29万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 36.29万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 36.29万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 36.29万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 36.29万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 36.29万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 36.29万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 36.29万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 36.29万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 36.29万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了